ngt-pharma-masthead

Customized Solutions for Complex Challenges

NGT BioPharma Consultants Leadership Team

Michael K. O’Brien, PhD
President & CEO
Mark Zettler, PhD
Executive VP Operations

Daniel Schaufelberger, PhD
VP Chemistry, Manufacturing & Controls​
Michelle McGuinness, MS
VP Regulatory Strategy & Submissions
Michael J. Neeb, PhD
VP Preclinical Development
Ronay LeBlanc, MA
VP Quality & Compliance
Francois Menard, PhD
VP Business Innovation
Edward Herpel NGT BioPharma Consultants
Ed Herpel, MA
Senior VP Business Effectiveness
Alton Johnson, NGT BioPharma Consultants
Alton Johnson, PhD
VP Biopharmaceutical Technology Innovation
Clinical Development
Leadership In Transition
Rachel Franckowiak, BA
Senior Executive Administrator
David Lowenschuss, JD 
VP General Counsel
Michael Placke, PhD, DABT
Michael Placke, PhD, DABT
Nonclinical Development & Drug Safety
Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs
 
Malcolm Berry, PhD
API Continuous Processing

Nancy C. Motola, PhD, RAC
Regulatory, Compliance, Quality Assurance
Michael Placke, NGT Biopharma Consultants
 
Michael Placke, PhD, DABT
Nonclinical Development
and Drug Safety

Leo Adalbert, NGT BioPharma Consultants

 
Leo J. Adalbert
Principal Consultant –
Strategic Commercialization

 
John L. Dillon, PhD
API Process R&D, Synthetic Organic Chemistry
 
Jeff Brum, PhD
Pharmaceutical Analysis – CMC Product Development

Robert Dennehy, PhD
API Crystallization and Solid State
 
Steve Hammond
Process Analytics and
PAT Innovator
 
Paul E. Luner, PhD
Oral Formulation Development & Physical Pharmaceutics
 
Frank P. Orlowski, MBA
Biotech and Life Sciences
Global Finance
 
Douglas Nesta, PhD
Chemistry, Manufacturing & Controls
 
Mike Webb, PhD
Chemistry, Manufacturing & Controls